[Ip-health] Bayer: A pharmaceutical company as an economic patient

James Love james.love at keionline.org
Fri Dec 7 02:43:44 PST 2018


https://www.handelsblatt.com/unternehmen/industrie/pharma-und-agrarchemiekonzern-kurssturz-klagen-kosten-wie-bayer-um-seine-zukunft-kaempft/23719478.html

This is a deep and extensive take-down of Bayer's failures in many areas,
by Handelsblatt.   My browser translated this into English, and it was
worth the time it took to read it.


More information about the Ip-health mailing list